Diabetic Neurological Disorder Therapeutic Drug Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Pills
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Symmetrical Neuropathy
1.3.3 Focal and Multifocal Neuropathy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2017-2028)
2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Region
2.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Region (2017-2022)
2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2023-2028)
2.3 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics
2.3.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends
2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers
2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges
2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue
3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2017-2022)
3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2017-2022)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio
3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2021
3.5 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Type
4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2017-2022)
4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2023-2028)
5 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Application
5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2017-2022)
5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
6.2.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
6.2.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
6.2.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
6.3.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
6.3.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
6.3.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
6.4.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
6.4.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
7.2.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
7.2.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
7.2.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
7.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
7.3.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
7.3.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
7.4.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
7.4.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
9.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
9.2.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
9.2.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
9.2.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
9.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
9.3.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
9.3.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
9.3.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
9.4 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
9.4.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
9.4.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction
11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction
11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction
11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.3.5 Takeda Recent Developments
11.4 Mitsubishi Chemical
11.4.1 Mitsubishi Chemical Company Details
11.4.2 Mitsubishi Chemical Business Overview
11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction
11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.4.5 Mitsubishi Chemical Recent Developments
11.5 Avanir Pharmaceuticals
11.5.1 Avanir Pharmaceuticals Company Details
11.5.2 Avanir Pharmaceuticals Business Overview
11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.5.5 Avanir Pharmaceuticals Recent Developments
11.6 Dong-A Pharmaceutical Co., Ltd.
11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details
11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview
11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction
11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Developments
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Company Details
11.7.2 Immune Pharmaceuticals Business Overview
11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.7.5 Immune Pharmaceuticals Recent Developments
11.8 MediciNova
11.8.1 MediciNova Company Details
11.8.2 MediciNova Business Overview
11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction
11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.8.5 MediciNova Recent Developments
11.9 Sangamo BioSciences
11.9.1 Sangamo BioSciences Company Details
11.9.2 Sangamo BioSciences Business Overview
11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction
11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
11.9.5 Sangamo BioSciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Capsule
Table 3. Key Players of Pills
Table 4. Key Players of Other
Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2017-2022)
Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2023-2028)
Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends
Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers
Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges
Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints
Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Players (2017-2022)
Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2021)
Table 18. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
Table 22. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2017-2022)
Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2023-2028)
Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2017-2022)
Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2023-2028)
Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product
Table 65. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 66. AstraZeneca Recent Developments
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product
Table 70. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 71. Johnson & Johnson Recent Developments
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Diabetic Neurological Disorder Therapeutic Drug Product
Table 75. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 76. Takeda Recent Developments
Table 77. Mitsubishi Chemical Company Details
Table 78. Mitsubishi Chemical Business Overview
Table 79. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product
Table 80. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 81. Mitsubishi Chemical Recent Developments
Table 82. Avanir Pharmaceuticals Company Details
Table 83. Avanir Pharmaceuticals Business Overview
Table 84. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 85. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 86. Avanir Pharmaceuticals Recent Developments
Table 87. Dong-A Pharmaceutical Co., Ltd. Company Details
Table 88. Dong-A Pharmaceutical Co., Ltd. Business Overview
Table 89. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product
Table 90. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 91. Dong-A Pharmaceutical Co., Ltd. Recent Developments
Table 92. Immune Pharmaceuticals Company Details
Table 93. Immune Pharmaceuticals Business Overview
Table 94. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 95. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 96. Immune Pharmaceuticals Recent Developments
Table 97. MediciNova Company Details
Table 98. MediciNova Business Overview
Table 99. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product
Table 100. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 101. MediciNova Recent Developments
Table 102. Sangamo BioSciences Company Details
Table 103. Sangamo BioSciences Business Overview
Table 104. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product
Table 105. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 106. Sangamo BioSciences Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2021 VS 2028
Figure 2. Capsule Features
Figure 3. Pills Features
Figure 4. Other Features
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2021 VS 2028
Figure 6. Symmetrical Neuropathy Case Studies
Figure 7. Focal and Multifocal Neuropathy Case Studies
Figure 8. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region: 2021 VS 2028
Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2021
Figure 13. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2021
Figure 15. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 17. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 19. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 23. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 24. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 25. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Region (2017-2028)
Figure 35. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 45. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 51. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 55. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 56. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 57. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 58. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 59. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 60. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 61. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 62. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
